Xencor (XNCR) Appoints Bart Cornelissen as Chief Financial Officer

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen [alumnus RSM MScBA] to senior vice president and chief financial officer

Read the article: https://www.streetinsider.com/Corporate+News/Xencor+%28XNCR%29+Appoints+Bart+Cornelissen+as+Chief+Financial+Officer/23043826.html

Participants

  • Bart Cornelissen
    Role: Alumni
    Reference type: Featured

Media Outlets

  • StreetInsider.com (Online)